Showing results (101-110 of 162) with videos related to
Sort By:
Pageof 17
Cancer Research|May 1, 1992
Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase geneJ K Owens, D S Shewach, B Ullman, et al.Clinical & Experimental Metastasis|March 1, 1996
CD44 exon variant 6 epitope and hyaluronate synthase are expressed on HT29 human colorectal carcinoma cells in a SCID mouse model of metastasis formationB S Mitchell, A Whitehouse, P Prehm, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1994
Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expressionJ S Dayton, T Lindsten, C B Thompson, et al.Biochemical Pharmacology|May 11, 1995
Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor bindingP W Hager, F R Collart, E Huberman, et al.Medical Education|March 16, 2002
The General Medical Council's Performance Procedures: peer review of performance in the workplaceL Southgate, J Cox, T David, et al.Blood|July 1, 1989
Erythrocyte adenosine deaminase overproduction in hereditary hemolytic anemiaE G Chottiner, D Ginsburg, A P Tartaglia, et al.Cancer Letters|February 14, 1998
Do HPA and PHA-L have the same binding pattern in metastasizing human breast and colon cancers?B S Mitchell, S A Brooks, A J Leathem, et al.Genomics|November 1, 1994
Assignment of the human type I IMP dehydrogenase gene (IMPDH1) to chromosome 7q31.3-q32)J J Gu, K Kaiser-Rogers, K Rao, et al.Cancer Research|March 1, 1985
Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblastsD S Shewach, P E Daddona, E Ashcraft, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1978
Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cellsB S Mitchell, E Mejias, P E Daddona, et al.Pageof 17